Cell viability rate of 5 μM CDDP treatment were measured by CCK-8 assay at different time points, which showed that overexpression of AKT2 rendered cancer cells more chemoresistance in miR-497-overexpressing lung cancer cells (Figure 6B). The gene discussed is AKT2; the disease is lung carcinoma.